Lenvatinib in combination with transarterial chemoembolization for treatment of unresectable hepatocellular carcinoma (uHCC): a retrospective controlled study

Purpose To compare the efficacy and safety of combined treatment with lenvatinib and transarterial chemoembolization (TACE) versus TACE only in patients with unresectable hepatocellular carcinoma (uHCC). Methods Of the 120 patients enrolled in this study, 60 patients received treatment with TACE onl...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Hepatology international 2021-06, Vol.15 (3), p.663-675
Hauptverfasser:	Fu, Zhigang, Li, Xiaowei, Zhong, Jiaming, Chen, Xiaoxia, Cao, Kunkun, Ding, Ning, Liu, Li, Zhang, Xiaoli, Zhai, Jian, Qu, Zengqiang
Format:	Artikel
Sprache:	eng
Schlagworte:	Adverse events Albumins Chemoembolization Clinical outcomes Colorectal Surgery Combined treatment Disease control Health services Hepatocellular carcinoma Hepatology Hypertension Liver cancer Medicine Medicine & Public Health Original Original Article Patients Safety Safety management Solid tumors Surgery Survival Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!